No. Management indicating reimbursment on CelGro Dental in Australia 2Q 2021. There will be other announcements before then. Suggest you go back and read quarterly reports and investor presentations. We are due a TGA Nerve submission in 4Q2020 or early 2021. Likely annoncement on FDA CelGro 510K study very shortly. Likely announcement on FDA CelGro Tendon pre-submission meeting, etc, etc....
Really wish people would check their facts if people are going to ascert things on here that effect other investors decisions.
Ann: CelGro Receives Australian Market Approval, page-9
Add OCC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
0.010(2.63%) |
Mkt cap ! $81.63M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 39.0¢ | 37.5¢ | $49.66K | 129.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 20305 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 77938 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| OCC (ASX) Chart |